SAB BIOTHERAPEUTICS, INC. (SABS) Capital expenditures 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$933,156FY2025 · since FY2020: $12.7M → $933,156
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $933,156 | +176.7% |
| FY2024 | $337,262 | +71.1% |
| FY2023 | $197,154 | -90.9% |
| FY2022 | $2.2M | -80.2% |
| FY2021 | $10.9M | -14.0% |
| FY2020 | $12.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice